MG53 slows neuromuscular junction loss and prolongs survival in ALS
J. Yi, A. Li, X. Li, K. H. Park, X. Zhou, F. Yi, Y. Xiao, D. Yoon, T. Tan, L. W. Ostrow, J. Ma, J. Zhou
This study shows that MG53 reduces neuromuscular junction loss and extends survival in ALS by protecting diaphragm muscle and NMJ integrity.
bioRxiv · Apr 22, 2021Cell Biology